Breakthrough Era in Endometrial Cancer Treatment: Highlights from ESMO 2023 - European Medical Journal

Breakthrough Era in Endometrial Cancer Treatment: Highlights from ESMO 2023

Oncology
Download PDF

Standard of Care for the Treatment of Endometrial Cancer: Change Is Afoot

This infographic was funded by a medical educational grant from GSK, with the purpose of enhancing the fundamental understanding of oncology specialists of key data and the latest advancements in endometrial cancer care.

This content is not intended for US Healthcare Professionals.

This striking infographic provides a fascinating snapshot of the highlights in endometrial cancer research presented at the European Society of Medical Oncology (ESMO) Congress in October 2023.

Following the practice-changing findings from the key Phase III clinical studies, RUBY and NRG-GY018, revealed at the Society of Gynecologic Oncology (SGO) Annual Meeting in March 2023, data from ESMO 2023 captured in this infographic show that research in endometrial cancer continues at a pace.

Rate this content's potential impact on patient outcomes

Thank you!

Please share some more information on the rating you have given